Role of presympathetic neurons of the hindbrain in cardiovascular control
Role of presympathetic neurons of the hindbrain in cardiovascular control
批准号:
10580717
负责人:
Stephen Abbott
金额:
$46.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-06-10 至 2025-02-28
关键词:
AcuteAnimalsBlood PressureBrainBrain StemCardiovascular DiseasesCardiovascular systemCarotid BodyCellsCessation of lifeChemoreceptorsChronicDataDevelopmentEssential HypertensionFunctional disorderGenerationsGeneticGenetic TranscriptionHeart DiseasesHeart failureHumanHyperactivityHypertensionHypoxemiaHypoxiaMediatingMethodsModelingMolecularMultiple System AtrophyNerveNeuronsNorepinephrineOutputOxidative StressPathway interactionsPatientsPlayPontine structureProbabilityRabies virusRattusRegulationResistanceRestRisk FactorsRodentRoleSleep Apnea SyndromesSourceSpinal CordStrokeSympathetic Nervous SystemSystemTestingTherapeuticblood pressure controlblood pressure elevationblood pressure regulationconnectomeexcitatory neurongenetic approachhindbrainhypertensiveknock-downneurogenic hypertensionnoradrenergicoptogeneticspreventreceptorrespiratorysingle nucleus RNA-sequencingtranscriptomevesicular monoamine transporter 2
中文摘要
联系PD/PI:Abbott,Stephen
项目摘要
高血压是心血管疾病发展的重要危险因素。尽管主要
治疗进展,高血压往往是治疗抵抗,仍然导致无数人死于中风
和心脏病。高血压可能是神经源性的,即它与慢性高血压有关,并可能由慢性高血压引起。
交感神经活性(SNA)的升高。SNA的这种提高有许多可疑的原因,例如
增加颈动脉体活性、脑干低氧血症和CNS氧化应激,但
最终介导SNA提升的原因还不清楚。原因之一是我们对
连接和功能的大多数脑干通路参与SNA的产生。
这项建议的重点是A5组后脑去甲肾上腺素能神经元的贡献,
国民账户体系的监管,
血压(BP)。这一选择是出于四个方面的考虑。首先,A5神经元
是交感节前神经元去甲肾上腺素能输入的主要来源。第二,去甲肾上腺素
对交感神经节前神经元产生强大的兴奋作用。第三,A5神经元强烈地
因此可以介导缺氧对SNA的一些影响,并有助于
缺氧引起的适应性变化。最后,去甲肾上腺素代谢物从脑中流出,
高血压人(MHPG)的CNS NA释放升高,这表明CNS NA释放可能异常高。
这四个方面的考虑表明,A5神经元过度活跃可能有助于神经源性高血压。
我将检验A5去甲肾上腺素能细胞通过刺激交感神经系统来激活交感神经系统的假设。
交感神经节前神经元通过NA释放。其次,我建议确定转录组,
连接体的A5神经元,并将它们与邻近的神经元,控制血压的吻侧
延髓腹外侧最后,我将测试
A5依赖性NA释放
原因
交感
多动症
睡眠呼吸暂停(急性间歇性缺氧)模型。了解后脑网络
控制交感神经系统可有益于与交感神经系统相关的任何病症的治疗
功能障碍,如神经源性高血压、心力衰竭和多系统萎缩。
第6页
项目总结/摘要
英文摘要
Contact PD/PI: Abbott, Stephen
Project summary
Hypertension is an important risk factor for the development of cardiovascular disease. Despite major
therapeutic advances, hypertension is often treatment resistant and still causes countless deaths from stroke
and heart disease. Hypertension may be neurogenic i.e. it is associated with and probably caused by a chronic
elevation of sympathetic nerve activity (SNA). This SNA elevation has many suspected causes such as an
increase in carotid body activity, brainstem hypoxemia and CNS oxidative stress but the CNS network that
ultimately mediates the SNA elevation is not well understood. One reason is our limited understanding of the
connections and function of most brainstem pathways implicated in the generation of SNA.
This proposal focuses on the contribution of the A5 group of hindbrain noradrenergic neurons to the
regulation of SNA and
blood pressure (BP). This choice is motivated by four considerations. First, A5 neurons
are the main source of noradrenergic input to sympathetic preganglionic neurons. Second, noradrenaline
exerts powerful excitatory effects on sympathetic preganglionic neurons. Third, A5 neurons are strongly
activated by hypoxia and therefore could mediate some of the effects of hypoxia on SNA and contribute to the
adaptive changes elicited by hypoxia. Lastly, the efflux of noradrenaline metabolites from the brain of
hypertensive humans (MHPG) is elevated, which suggests that CNS NA-release may be abnormally high.
These four considerations suggest that A5 neurons hyperactivity could contribute to neurogenic hypertension.
I will test the hypothesis that A5 noradrenergic cells activate the sympathetic nervous system by exciting
sympathetic preganglionic neurons via NA-release. Second, I propose to determine the transcriptome and
connectome of A5 neurons, and compare them with that of neighboring neurons that control BP in the rostral
ventrolateral medulla. And finally, I will test whether
A5-dependent NA-release
causes
sympathetic
hyperactivity in
a model of sleep apnea (acute intermittent hypoxia). Understanding the hindbrain networks
controlling the sympathetic system may benefit the treatment of any condition associated with sympathetic
dysfunction, like neurogenic hypertension, heart failure and multiple systems atrophy.
Page 6
Project Summary/Abstract
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Brain Pathways in Blood Pressure Regulation.
血压调节的大脑通路。
DOI:
10.1161/hypertensionaha.123.21723
发表时间:
2024
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
[Stocker,SeanD, Ferreira,CarolineB, Souza,GeorgeMPR, Abbott,StephenBG]
通讯作者:
Abbott,StephenBG
DOI:
10.1016/j.resp.2024.104217
发表时间:
2024-01-20
期刊:
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
影响因子:
2.3
作者:
[Souza,George M. P. R., Abbott,Stephen B. G.]
通讯作者:
Abbott,Stephen B. G.
The arcuate nucleus: A site of synergism between Angiotensin II and leptin to increase sympathetic nerve activity and blood pressure in rats.
弓状核:血管紧张素 II 和瘦素之间的协同作用位点,可增加大鼠的交感神经活动和血压。
DOI:
10.1016/j.neulet.2022.136773
发表时间:
2022
期刊:
Neuroscience letters
影响因子:
2.5
作者:
[Shi,Zhigang, Stornetta,RuthL, Stornetta,DanielS, Abbott,StephenBG, Brooks,VirginiaL]
通讯作者:
Brooks,VirginiaL
Neuromedin B-Expressing Neurons in the Retrotrapezoid Nucleus Regulate Respiratory Homeostasis and Promote Stable Breathing in Adult Mice.
梯形后核中表达 Neuromedin B 的神经元可调节成年小鼠的呼吸稳态并促进稳定呼吸。
DOI:
10.1523/jneurosci.0386-23.2023
发表时间:
2023
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
[Souza,GeorgeMPR, Stornetta,DanielS, Shi,Yingtang, Lim,Eunu, Berry,FayeE, Bayliss,DouglasA, Abbott,StephenBG]
通讯作者:
Abbott,StephenBG
JP-RL-2023-285396: Reply to 'Letter to the Editor' (JP-LE-2023-285385).
JP-RL-2023-285396:回复“致编辑的信”(JP-LE-2023-285385)。
DOI:
10.1113/jp285396
发表时间:
2023
期刊:
The Journal of physiology
影响因子:
--
作者:
[Li,Keyong, Abbott,StephenBG, Guyenet,PatriceG, Bayliss,DouglasA]
通讯作者:
Bayliss,DouglasA
Role of presympathetic neurons of the hindbrain in cardiovascular control
-
批准号:10116460
-
项目类别:
-
资助金额:$54.28万
-
财政年份:2019
-
负责人:Stephen Abbott
-
依托单位:
Role of presympathetic neurons of the hindbrain in cardiovascular control
-
批准号:10368101
-
项目类别:
-
资助金额:$46.88万
-
财政年份:2019
-
负责人:Stephen Abbott
-
依托单位:
海外基金